Oncogene - Table of Contents alert Volume 35 Issue 21

If you are unable to see the message below, click here to view.

Advertisement First CRISPR/Cas9 antibody validated for chromatin immunoprecipitation A new addition to Diagenode's Cas9 collection! Recognizes the C-terminus of the Cas9 nuclease Ideal for fusion protein experiments Validated in IP, WB and IF  Learn more and get best quality data TABLE OF CONTENTS Volume 35, Issue 21 (May 2016) In this issue Commentaries Original Articles Corrigendum Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement View most cited articles - which ones have you missed? Take a look at what your colleagues have been citing across the Oncogene journal over the past two years.  Click here to visit special webpage Commentaries Top More complex transcriptional regulation and stress response by MOF N Horikoshi, C R Hunt and T K Pandita Oncogene 2016 35: 2681-2683; advance online publication, October 5, 2015; 10.1038/onc.2015.373 Abstract | Full Text TAMing resistance to multi-targeted kinase inhibitors through Axl and Met inhibition D J Pinato, S Chowdhury and J Stebbing Oncogene 2016 35: 2684-2686; advance online publication, October 5, 2015; 10.1038/onc.2015.374 Abstract | Full Text Original Articles Top Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma L Zhou, X-D Liu, M Sun, X Zhang, P German, S Bai, Z Ding, N Tannir, C G Wood, S F Matin, J A Karam, P Tamboli, K Sircar, P Rao, E B Rankin, D A Laird, A G Hoang, C L Walker, A J Giaccia and E Jonasch Oncogene 2016 35: 2687-2697; advance online publication, September 14, 2015; 10.1038/onc.2015.343 Abstract | Full Text MOF maintains transcriptional programs regulating cellular stress response OPEN B N Sheikh, W Bechtel-Walz, J Lucci, O Karpiuk, I Hild, B Hartleben, J Vornweg, M Helmstädter, A H Sahyoun, V Bhardwaj, T Stehle, S Diehl, O Kretz, A K Voss, T Thomas, T Manke, T B Huber and A Akhtar Oncogene 2016 35: 2698-2710; advance online publication, September 21, 2015; 10.1038/onc.2015.335 Abstract | Full Text Structural centrosome aberrations favor proliferation by abrogating microtubule-dependent tissue integrity of breast epithelial mammospheres OPEN D Schnerch and E A Nigg Oncogene 2016 35: 2711-2722; advance online publication, September 14, 2015; 10.1038/onc.2015.332 Abstract | Full Text Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma M B Meads, B Fang, L Mathews, J Gemmer, L Nong, I Rosado-Lopez, T Nguyen, J E Ring, W Matsui, A R MacLeod, J A Pachter, L A Hazlehurst, J M Koomen and K H Shain Oncogene 2016 35: 2723-2734; advance online publication, September 21, 2015; 10.1038/onc.2015.334 Abstract | Full Text NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2 G M De Donatis, E L Pape, A Pierron, Y Cheli, V Hofman, P Hofman, M Allegra, K Zahaf, P Bahadoran, S Rocchi, C Bertolotto, R Ballotti and T Passeron Oncogene 2016 35: 2735-2745; advance online publication, September 14, 2015; 10.1038/onc.2015.331 Abstract | Full Text LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer X Xue, Y A Yang, A Zhang, K-W Fong, J Kim, B Song, S Li, J C Zhao and J Yu Oncogene 2016 35: 2746-2755; advance online publication, September 14, 2015; 10.1038/onc.2015.340 Abstract | Full Text Breast cancer dissemination promoted by a neuregulin-collagenase 3 signalling node S Seoane, J C Montero, A Ocaña and A Pandiella Oncogene 2016 35: 2756-2765; advance online publication, September 14, 2015; 10.1038/onc.2015.337 Abstract | Full Text Systematic integration of molecular profiles identifies miR-22 as a regulator of lipid and folate metabolism in breast cancer cells C Koufaris, G N Valbuena, Y Pomyen, G D Tredwell, E Nevedomskaya, C-HE Lau, T Yang, A Benito, J K Ellis and H C Keun Oncogene 2016 35: 2766-2776; advance online publication, October 19, 2015; 10.1038/onc.2015.333 Abstract | Full Text Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors I Ferrer, E M Verdugo-Sivianes, M A Castilla, R Melendez, J J Marin, S Muñoz-Galvan, J L Lopez-Guerra, B Vieites, M J Ortiz-Gordillo, J M De León, J M Praena-Fernandez, M Perez, J Palacios and A Carnero Oncogene 2016 35: 2777-2788; advance online publication, September 21, 2015; 10.1038/onc.2015.341 Abstract | Full Text Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial–mesenchymal transition and metastasis in a YAP-independent manner Y Liu, G Wang, Y Yang, Z Mei, Z Liang, A Cui, T Wu, C-Y Liu and L Cui Oncogene 2016 35: 2789-2800; advance online publication, September 21, 2015; 10.1038/onc.2015.342 Abstract | Full Text Ceramide limits phosphatidylinositol-3-kinase C2β-controlled cell motility in ovarian cancer: potential of ceramide as a metastasis-suppressor lipid K Kitatani, T Usui, S K Sriraman, M Toyoshima, M Ishibashi, S Shigeta, S Nagase, M Sakamoto, H Ogiso, T Okazaki, Y A Hannun, V P Torchilin and N Yaegashi Oncogene 2016 35: 2801-2812; advance online publication, September 14, 2015; 10.1038/onc.2015.330 Abstract | Full Text Corrigendum Top NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2 G M De Donatis, E Le Pape, A Pierron, Y Cheli, V Hofman, P Hofman, M Allegra, K Zahaf, P Bahadoran, S Rocchi, C Bertolotto, R Ballotti and T Passeron Oncogene 2016 35: 2813; 10.1038/onc.2015.468 Full Text Advertisement Nature Partner Journals: a new home for your research Over the last two years we have collaborated with over 20 internationally renowned partner organizations to publish cutting-edge open articles in disciplines covering all aspects of research science. Visit our interactive timeline to explore the Nature Partner Journals series and our highlights and milestones so far.  Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.